EpiPens aren’t part of a free market at all.
Jeffrey Carter

If the cost of innovation is so high, then why are billions being invested here, and venture capital at record levels?

One clap, two clap, three clap, forty?

By clapping more or less, you can signal to us which stories really stand out.